Free Trial

Jitendra Mohan Sells 76,258 Shares of Astera Labs, Inc. (NASDAQ:ALAB) Stock

Astera Labs logo with Computer and Technology background

Astera Labs, Inc. (NASDAQ:ALAB - Get Free Report) CEO Jitendra Mohan sold 76,258 shares of Astera Labs stock in a transaction on Monday, July 21st. The shares were sold at an average price of $112.72, for a total transaction of $8,595,801.76. Following the completion of the sale, the chief executive officer owned 475,421 shares in the company, valued at $53,589,455.12. The trade was a 13.82% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Jitendra Mohan also recently made the following trade(s):

  • On Friday, July 18th, Jitendra Mohan sold 45,755 shares of Astera Labs stock. The shares were sold at an average price of $100.25, for a total transaction of $4,586,938.75.
  • On Thursday, July 17th, Jitendra Mohan sold 80,503 shares of Astera Labs stock. The shares were sold at an average price of $94.37, for a total transaction of $7,597,068.11.
  • On Thursday, July 10th, Jitendra Mohan sold 11,282 shares of Astera Labs stock. The shares were sold at an average price of $102.46, for a total transaction of $1,155,953.72.
  • On Wednesday, July 9th, Jitendra Mohan sold 6,982 shares of Astera Labs stock. The stock was sold at an average price of $100.01, for a total transaction of $698,269.82.
  • On Friday, June 20th, Jitendra Mohan sold 52,743 shares of Astera Labs stock. The stock was sold at an average price of $100.86, for a total transaction of $5,319,658.98.
  • On Tuesday, June 17th, Jitendra Mohan sold 106,510 shares of Astera Labs stock. The stock was sold at an average price of $94.54, for a total transaction of $10,069,455.40.
  • On Thursday, May 29th, Jitendra Mohan sold 14,200 shares of Astera Labs stock. The stock was sold at an average price of $100.00, for a total transaction of $1,420,000.00.
  • On Monday, May 19th, Jitendra Mohan sold 128,250 shares of Astera Labs stock. The shares were sold at an average price of $90.02, for a total transaction of $11,545,065.00.
  • On Friday, May 16th, Jitendra Mohan sold 91,337 shares of Astera Labs stock. The stock was sold at an average price of $90.67, for a total transaction of $8,281,525.79.
  • On Wednesday, May 14th, Jitendra Mohan sold 75,000 shares of Astera Labs stock. The stock was sold at an average price of $90.90, for a total transaction of $6,817,500.00.

Astera Labs Price Performance

Shares of ALAB stock traded up $1.05 on Friday, hitting $122.73. The stock had a trading volume of 1,560,598 shares, compared to its average volume of 4,743,873. The business has a 50 day moving average of $95.39 and a 200 day moving average of $86.49. The stock has a market cap of $20.24 billion, a price-to-earnings ratio of 558.18, a price-to-earnings-growth ratio of 5.61 and a beta of 1.18. Astera Labs, Inc. has a 12-month low of $36.22 and a 12-month high of $147.39.

Astera Labs (NASDAQ:ALAB - Get Free Report) last posted its quarterly earnings data on Tuesday, May 6th. The company reported $0.33 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.28 by $0.05. Astera Labs had a net margin of 8.44% and a return on equity of 2.57%. The business had revenue of $159.44 million during the quarter, compared to the consensus estimate of $151.55 million. During the same quarter last year, the company posted $0.10 earnings per share. The firm's quarterly revenue was up 144.1% compared to the same quarter last year. As a group, research analysts expect that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on ALAB shares. Morgan Stanley raised shares of Astera Labs from an "equal weight" rating to an "overweight" rating and set a $99.00 target price on the stock in a report on Monday, May 12th. Citigroup reduced their price objective on shares of Astera Labs from $120.00 to $100.00 and set a "buy" rating on the stock in a research note on Monday, April 14th. Northland Securities lowered shares of Astera Labs from an "outperform" rating to a "market perform" rating and set a $120.00 price objective on the stock. in a research note on Tuesday. Evercore ISI upped their price objective on shares of Astera Labs from $87.00 to $104.00 and gave the company an "outperform" rating in a research note on Wednesday, May 21st. Finally, Wall Street Zen lowered shares of Astera Labs from a "buy" rating to a "hold" rating in a research note on Saturday, July 12th. Four research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the stock. Based on data from MarketBeat.com, Astera Labs presently has a consensus rating of "Moderate Buy" and an average price target of $102.67.

Read Our Latest Report on ALAB

Hedge Funds Weigh In On Astera Labs

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. CWM LLC boosted its position in shares of Astera Labs by 79.3% in the second quarter. CWM LLC now owns 6,734 shares of the company's stock valued at $609,000 after acquiring an additional 2,979 shares during the period. Vanguard Personalized Indexing Management LLC raised its stake in shares of Astera Labs by 142.4% during the second quarter. Vanguard Personalized Indexing Management LLC now owns 11,366 shares of the company's stock worth $1,028,000 after acquiring an additional 6,677 shares in the last quarter. Bernard Wealth Management Corp. purchased a new position in shares of Astera Labs during the second quarter worth approximately $36,000. IFP Advisors Inc raised its stake in shares of Astera Labs by 61.5% during the second quarter. IFP Advisors Inc now owns 4,135 shares of the company's stock worth $378,000 after acquiring an additional 1,575 shares in the last quarter. Finally, Callan Family Office LLC purchased a new position in shares of Astera Labs during the second quarter worth approximately $260,000. Institutional investors own 60.47% of the company's stock.

About Astera Labs

(Get Free Report)

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

Read More

Insider Buying and Selling by Quarter for Astera Labs (NASDAQ:ALAB)

Should You Invest $1,000 in Astera Labs Right Now?

Before you consider Astera Labs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astera Labs wasn't on the list.

While Astera Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 “Boring” Mega Cap Stocks to Turn Into Pure Profit
Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines